GLP-1s like Ozempic, Mounjaro may cut fracture risk in type 2 diabetes
New evidence suggests that medications in the GLP-1 family, including semaglutide (branded as Ozempic) and the dual GIP/GLP-1 agent tirzepatide (Mounjaro), may do more than … Read more